Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care [Phase 2]
Phase 2 trial evaluating ketamine for depression in cancer patients receiving palliative care has been completed.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept [Phase 2]
A Phase 2 proof-of-concept study evaluating the clinical, neurocognitive, and emotional effects of psilocybin in patients with major depress…
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Contact: Developing New Clinical Management Strategies [Phase 4]
Phase 4 clinical trial on developing new management strategies for major depressive disorder has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: A Virtual Navigation Intervention to Reduce Behavioral Health Admissions From Rural Emergency Departments [NA]
A completed clinical trial evaluating a virtual navigation intervention to reduce behavioral health admissions from rural emergency departme…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress [Phase 2]
Phase 2 trial results for JNJ-42165279 in adults with major depressive disorder with anxious distress, detailing efficacy, safety and tolera…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD) [Phase 3]
Phase 3 trial comparing pipamperone/citalopram combination to citalopram alone and to pipamperone alone in major depressive disorder has com…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment [Phase 3]
Phase 3 extension study of pimavanserin as adjunctive treatment for major depressive disorder with inadequate response to antidepressants; t…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and Safety [NA]
A completed substudy of a clinical trial evaluating mPATH's effect on screening for depression among participants; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression [Phase 3]
Phase 3 trial investigating the efficacy of Trial-Based Cognitive Therapy and Behavioral Activation for Major Depressive Disorder has comple…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Sunshine 2 Study for Women With Diabetes [Phase 2]
Phase 2 clinical trial update for the Sunshine 2 Study in women with diabetes, assessing diabetes and depression-related outcomes and qualit…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: IntelliCare in College Students - Implementation (ICCS-I) [NA]
Clinical trial update for IntelliCare in college students showing completion and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Antidepressant Response in Older Adults With Comorbid PTSD and MDD [Phase 4]
Phase 4 trial assessing antidepressant response in older adults with comorbid PTSD and major depressive disorder has been terminated with re…
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder [Phase 3]
Phase 3 trial assessing efficacy, safety, and tolerability of levomilnacipran ER in pediatric patients (7-17) with major depressive disorder…
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Home-based tDCS in Major Depressive Disorder [NA]
Clinical trial update for home-based transcranial direct current stimulation (tDCS) in major depressive disorder; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Treatments for Improving Mood in Depressed Teens-2 [NA]
Clinical trial update for treatments aimed at improving mood in depressed teenagers; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder Patients [Phase 2]
Phase 2 trial evaluating magnesium supplementation in patients with major depressive disorder treated with SSRIs has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India [Phase 4]
Open-label, flexible-dose Phase 4 trial of vortioxetine in India for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Efficacy of Clinical Application of Transcranial Low Intensity Focused Ultrasonic Stimulation for Patients With Major Deperessive Disorder - Exploratory Clinical Trial [Phase 3]
Exploratory Phase 3 clinical trial evaluating transcranial low-intensity focused ultrasonic stimulation for major depressive disorder has co…
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Text2Connect, Component 2 of iCHART (Integrated Care to Help At-Risk Teens) [NA]
Clinical trial completed for Text2Connect component of iCHART targeting depressed teens with suicidal ideation; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: Healthy Heart Habits [Phase 1, Phase 2]
Clinical trial update for Healthy Heart Habits reporting Phase 1 and Phase 2 results; completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-03Clinical Trial Update: EM/PROTECT: Improving Depression in Elder Mistreatment Victims [NA]
A completed clinical trial investigating methods to improve depression in elderly victims of mistreatment; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder [Phase 2]
Phase 2 clinical trial investigating the antidepressant effects of AV-101 (4-chlorokynurenine), a glycine receptor antagonist, in major depr…
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Development and Testing of a Behavioral Activation Mobile Therapy for Elevated Depressive Systems [NA]
A completed clinical trial evaluating a behavioral activation mobile therapy for depression; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Pilot Study of Annie Text Messaging for Depression Treatment Adherence [NA]
A completed pilot clinical trial evaluating Annie text messaging to improve treatment adherence for depression; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators [NA]
A completed clinical trial evaluated whether treating caregiver depression improves childhood asthma outcomes and explored mediators of any …